The title compound, C13H16N10O5S (systematic name: 1-(4,6-dimethoxypyrimidin-2-yl)-3-{[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-yl]sulfonyl}urea), is a second triclinic polymorph of this crystal [for the other, see: Jeon et al., (2015). Acta Cryst. E71, o470–o471]. There are two molecules, A and B, in the asymmetric unit; the dihedral angles between the pyrazole ring and the tetrazole and dimethoxypyrimidine ring planes are 72.84 (10) and 37.24 (14)°, respectively (molecule A) and 84.38 (9) and 26.09 (15)°, respectively (molecule B). Each molecule features an intramolecular N—H...N hydrogen bond. In the crystal, aromatic π–π stacking interactions [centroid–centroid separations = 3.9871 (16), 3.4487 (14) and 3.5455 (16) Å] link the mo...
R factor = 0.036; wR factor = 0.098; data-to-parameter ratio = 11.8. The title compound, C16H14O5, i...
The title compound, C11H13NO6, shows two polymorphs, orange and yellow forms, both of which crystall...
There are two crystallographically independent molecules in the asymmetric unit of the title compoun...
The title compound, C12H13N5O2S {systematic name: ethyl N-[N-(3-phenyl-1H-1,2,4-triazol-5-yl)carbamo...
[Introduction] The title compound, C 14 H 16 N 6 O 2 , is a second monoclinic polymorph of ...
R factor = 0.049; wR factor = 0.155; data-to-parameter ratio = 24.4. The title compound, C14H13NO3S,...
The title compound {systematic name: 1-(4,6-dimethoxy-pyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tet...
The asymmetric unit of the triclinic polymorph of the title compound, C21H25N3O3, consists of two mo...
The title compound, C14H13NO3S, (I), is a second monoclinic polymorph. The original polymorph, (II),...
The molecule of the title compound, C9H9N5O, is approximately planar (the r.m.s. deviation of all no...
0.044; wR factor = 0.087; data-to-parameter ratio = 15.9. The sulfathiazole molecule in the title 1:...
The title compound, C3H3N3S3, is a triclinic modification. The other reported modification crystalli...
The title compound, C9H11N3O2S, is a second monoclinic (P21/c) polymorph of the previously reported ...
The crystal structure of the title compound, C(17)H(28)O(5), reported here is a polymorph of the str...
The title compound, C6H6N6S, crystallized with two independent molecules (A and B) in the asymmetric...
R factor = 0.036; wR factor = 0.098; data-to-parameter ratio = 11.8. The title compound, C16H14O5, i...
The title compound, C11H13NO6, shows two polymorphs, orange and yellow forms, both of which crystall...
There are two crystallographically independent molecules in the asymmetric unit of the title compoun...
The title compound, C12H13N5O2S {systematic name: ethyl N-[N-(3-phenyl-1H-1,2,4-triazol-5-yl)carbamo...
[Introduction] The title compound, C 14 H 16 N 6 O 2 , is a second monoclinic polymorph of ...
R factor = 0.049; wR factor = 0.155; data-to-parameter ratio = 24.4. The title compound, C14H13NO3S,...
The title compound {systematic name: 1-(4,6-dimethoxy-pyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tet...
The asymmetric unit of the triclinic polymorph of the title compound, C21H25N3O3, consists of two mo...
The title compound, C14H13NO3S, (I), is a second monoclinic polymorph. The original polymorph, (II),...
The molecule of the title compound, C9H9N5O, is approximately planar (the r.m.s. deviation of all no...
0.044; wR factor = 0.087; data-to-parameter ratio = 15.9. The sulfathiazole molecule in the title 1:...
The title compound, C3H3N3S3, is a triclinic modification. The other reported modification crystalli...
The title compound, C9H11N3O2S, is a second monoclinic (P21/c) polymorph of the previously reported ...
The crystal structure of the title compound, C(17)H(28)O(5), reported here is a polymorph of the str...
The title compound, C6H6N6S, crystallized with two independent molecules (A and B) in the asymmetric...
R factor = 0.036; wR factor = 0.098; data-to-parameter ratio = 11.8. The title compound, C16H14O5, i...
The title compound, C11H13NO6, shows two polymorphs, orange and yellow forms, both of which crystall...
There are two crystallographically independent molecules in the asymmetric unit of the title compoun...